Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial-Reference-Cited by-同舟云学术

Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial

Published:2017-06-01 Issue:6 Volume:32 Page:1060-1070
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Budde Klemens¹,Zeier Martin²,Witzke Oliver³,Arns Wolfgang⁴,Lehner Frank⁵,Guba Markus⁶,Jacobi Johannes⁷,Kliem Volker⁸,Reinke Petra⁹,Hauser Ingeborg A.¹⁰,Vogt Bruno¹¹,Stahl Rolf¹²,Rath Thomas¹³,Duerr Michael¹,Paulus Eva-Maria¹⁴,May Christoph¹⁴,Porstner Martina¹⁴,Sommerer Claudia²,

Affiliation:

1. Department of Nephrology, Charité Universitätsmedizin Berlin, Berlin, Germany

2. Department of Nephrology, University of Heidelberg, Heidelberg, Germany

3. Department of Infectious Diseases and Department of Nephrology, University Duisburg-Essen, Essen, Germany

4. Department of Nephrology and Transplantation, Cologne Merheim Medical Centre, Cologne, Germany

5. Department of General, Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany

6. Department of General, Visceral and Transplantation Surgery, Munich University Hospital, Campus Grosshadern, Munich, Germany

7. Department of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen, Germany

8. Department of Internal Medicine and Nephrology, Kidney Transplant Centre, Nephrological Centre of Lower Saxony, Klinikum Hann. Münden, Germany

9. Department of Nephrology and Intensive Care, Charité Campus Virchow, Charité-Universitätsmedizin Berlin, Berlin, Germany

10. Department of Nephrology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany

11. Department of Nephrology and Hypertension, Inselspital, Bern, Switzerland

12. III. Medical Clinic, University Hospital Hamburg, Hamburg, Germany

13. University Hospital Westpfalz, Kaiserslautern, Germany

14. Novartis Pharma GmbH, Nuernberg, Germany

Funder

Novartis Pharma GmbH, Nuernberg, Germany

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/32/6/1060/17701466/gfx075.pdf

Reference40 articles.

1. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling;Abraham;Curr Opin Immunol,1998

2. mTOR inhibition: the learning curve in kidney transplantation;Weir;Transpl Int,2010

3. mTOR inhibitor/proliferation signal inhibitors: entering or leaving the field?;Rostaing;J Nephrol,2010

4. Reduced exposure to calcineurin inhibitors in renal transplantation;Ekberg;N Engl J Med,2007

5. Everolimus in clinical practice–renal transplantation;Pascual;Nephrol Dial Transplant,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

2. A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation;Asian Biomedicine;2024-06-01

3. The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta‐analysis;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-04-10

4. Everolimus Use in Lung Transplant Recipients;Transplantation Proceedings;2022-10

5. Effect of Sirolimus vs. Everolimus on CMV-Infections after Kidney Transplantation—A Network Meta-Analysis;Journal of Clinical Medicine;2022-07-20